CSIMarket
 




Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 



RVMD Price to Sales Ratio (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Sales Trailing 12 Months III. Quarter II. Quarter I. Quarter IV. Quarter III. Quarter
Price to Sales (TTM) Ratio current            -            93.28            63.74            53.89            59.43
Revenue TTM Y / Y Change - % 8.33 % 29.73 % 20.38 % 2.89 %
Revenue Y / Y Change - % -58.05 % -7.44 % 62.05 % 204.81 %
Stock performance to date 15.08 % 10.06 % -13.26 % 28.62 % 2.22 %

Price to sales ratio Comment
Revolution Medicines Inc recorded loss in trailing twelve months.

Within Healthcare sector 19 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Revolution Medicines Inc Segment

Price to sales ratio Company Ranking
Within: No.
Industry #2
Sector #20
S&P 500 #144






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com